- Home
- MSLE vs EML Comparison
MSLE vs EML Comparison
Compare MSLE & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSLE | EML |
|---|---|---|
| Founded | N/A | 1858 |
| Country | Canada | United States |
| Employees | 17 | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 119.2M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | MSLE | EML |
|---|---|---|
| Price | $7.17 | $21.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 103.3K | 12.0K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | N/A | ★ 185.40 |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $248,970,345.00 |
| Revenue This Year | N/A | $19.05 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $17.61 |
| 52 Week High | $13.39 | $26.76 |
Technical Indicators
Market Signals| Indicator | MSLE | EML |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 64.61 |
| Support Level | $6.67 | $18.85 |
| Resistance Level | $7.52 | $24.15 |
| Average True Range (ATR) | 0.66 | 0.58 |
| MACD | 0.27 | 0.12 |
| Stochastic Oscillator | 83.65 | 78.55 |
Price Performance
Historical ComparisonAbout MSLE Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.